A normal genetic variation modulates synaptic MMP‐9 protein levels and the severity of schizophrenia symptoms

Matrix metalloproteinase 9 (MMP‐9) has recently emerged as a molecule that contributes to pathological synaptic plasticity in schizophrenia, but explanation of the underlying mechanisms has been missing. In the present study, we performed a phenotype‐based genetic association study (PGAS) in > 1,...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EMBO Mol Med
Auteurs principaux: Lepeta, Katarzyna, Purzycka, Katarzyna J, Pachulska‐Wieczorek, Katarzyna, Mitjans, Marina, Begemann, Martin, Vafadari, Behnam, Bijata, Krystian, Adamiak, Ryszard W, Ehrenreich, Hannelore, Dziembowska, Magdalena, Kaczmarek, Leszek
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2017
Sujets:
Research Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5538295/
https://ncbi.nlm.nih.gov/pubmed/28623238
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201707723
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires